Delivery Order SPE2DB22D1106-SPE2DB25FERY5

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS CAPS 39.2MG/7.8MG, a pharmaceutical product. The contract has a ceiling value of $1,537.26 and a period of performance through May 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a $1,797.13 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product, with a performance period ending on May 22, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price of $2,941.40 and a completion date of May 1, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price of $1,493.44 and an ultimate completion date of May 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,115.10, is for the delivery of the drug product AZSTARYS 52.3 MG-10.4 MG CAP 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S pharmaceutical products, with a completion date of February 14, 2024 and a potential value of $1,240.81. This delivery order contract is part of a larger indefinite delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,983.06, is for the supply of AZSTARYS 26.1 MG-5.2 MG CAP 100S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 2, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
This is a $5,408.10 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for AZSTARYS CAPS 39.2MG/7.8MG medical supplies. The contract is not set-aside and has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a global pharmaceutical support vehicle through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,779.20 fixed-price delivery order is for AZSTARYS CAPS 26.1MG/5.2MG, a pharmaceutical product, with a performance period ending on May 19, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,148.68 and is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FERY5
    Delivery Order

This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a prescription medication, with a ceiling value of $2,873.68. The contract has a firm-fixed-price pricing type and a period of performance ending on June 6, 2025.

AmerisourceBergen Drug Corp is the prime contractor for this award, and there is no indication of any subcontractors involved. The contract is not set-aside, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This positions the company as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/4/25, 10:07 AM